Adenosine is known to modulate neuronal activity within the nucleus tractus solitarius (NTS).
Introduction
Adenosine is an endogenous nucleoside that generally acts as a neuromodulator in the central nervous system (CNS). Its actions are mediated by adenosine receptors, four of which have been cloned and pharmacologically characterized: A 1 , A 2A , A 2B , and A 3 ( 1 ) . Among the four subtypes, A 1 and A 2A are associated with behavioral effects that are exhibited in animals treated with adenosine analogs ( 2 ) . Numerous studies have shown substantial evidence that adenosine modulates cardiovascular control at the level of the nucleus tractus solitarius (NTS) ( 3 -6 ) . However, the exact mechanism of this modulation is not well understood.
The NTS is the main nucleus responsible for integrating different signals from other brain nuclei or organs in order to originate a specific and orchestrated regional autonomic response. This nucleus contains the greatest density of adeno-sine uptake sites in the CNS ( 7 ) . Adenosine is released within the NTS, primarily by the baroreceptor afferent and hypothalamic defense areas ( 8 ) . Barraco and Phillis ( 4 ) have reported that stimulation of adenosine A 1 and A 2A receptors in subpostremal NTS evokes pressor and depressor responses, respectively. Such experiments also increase or decrease the heart rate and other regional sympathetic activity ( 9 , 10 ). Scislo and O'Leary ( 6 ) have shown that in approximately 30% of cases a biphasic or depressor response may be elicited by stimulation of the adenosine A 1 receptor.
This finding suggests that adenosine A 1 receptors may regulate the pressor response in a certain way within the context of more complex NTS processing. Indeed, studies from our laboratory ( 11 ) have reported that adenosine A 1 receptors are heterogeneously distributed in three subnuclei located longitudinally from the rostral to the caudal NTS, namely the dorsolateral/dorsomedial, medial/intermediate, and subpostremal NTS subnuclei. This might partially explain the complex responses promoted by adenosine A 1 receptors within the NTS circuitry, although the biphasic or depressor responses are not yet understood.
Changing receptor function with the stimulation of other receptor, namely receptor crosstalk, has been extensively studied for noradrenergic axon terminals ( 12 ) . The noradrenergic neurons of the CNS are endowed with presynaptic receptors by which noradrenaline release is inhibited by noradrenaline itself ( via α 2 -autoreceptor) and by other neurotransmitters ( via heteroreceptors) like adenosine A 1 receptor ( 13 , 14 ) . The interaction between receptors has also been studied and characterized in other systems, including those that feature the well-known adenosine A 2 /dopamine D 2 interaction ( 15 -17 ) .
The noradrenergic system is well characterized in the NTS ( 18 ) . Stimulation of α 2 -adrenoceptor within this nucleus promotes a hypotensive response ( 19 ) . Adenosine A 1 receptors have been specially reported to modulate the α 2 -adrenoceptors in the hippocampus and spinal cord ( 13 , 14 ) . Both types of receptors are abundant in the NTS and their activation leads to cardiovascular changes ( 13 , 14 , 20 ) . In this context, we could postulate that adenosine A 1 receptor activation might intensify the hypotensive response promoted by noradrenaline action within the NTS, thereby explaining the biphasic or depressor responses observed by Scislo and O'Leary ( 6 ) . Taken together, this may indicate a possible interaction between adenosine A 1 receptors and α 2 -adrenoceptors within the NTS. This possibility may, in turn, be relevant for central cardiovascular control and therapeutic treatments.
The medulla oblongata, the region where the NTS is located, is the only brain area that shows significantly lower levels of noradrenaline and a reduced number and affinity of α 2 -adrenoceptors in spontaneously hypertensive rat (SHR) compared with the normotensive Wistar Kyoto (WKY) rat. This is true even as early as 4 weeks after birth, when hypertension is not yet apparent. This result suggests that certain mechanisms in the NTS α 2 -adrenergic transmission system may be altered and could trigger the development of hypertension in SHR ( 21 ) . Functional defects have been reported in purinergic neurotransmission related to the development of arterial hypertension in SHR ( 22 ) . Long-term treatment with 1,3-dipropyl-8-p -sulfophenylxanthine (DPSPX), a non-selective antagonist of the adenosine receptor, causes a hypertensive state in rats. In addition, exogenous adenosine interferes differently with the noradrenergic neurotransmission in SHR compared with WKY ( 23 ); thus, the cardiovascular regulation of arterial pressure in SHR within the NTS is dependent on NTS noradrenergic mechanisms and on purinergic neurotransmission.
In light of this, we speculate that adenosine might interact with the noradrenergic system within the NTS in order to modulate certain particular autonomic responses and that it might be relevant in the development of hypertension. The aim of the present study is to provide evidence for the existence of an α 2 -adrenergic/adenosine A 1 interaction within the NTS of normotensive and hypertensive rats.
Methods

Animals
Adult male WKY rats and SHR from the Institute of Biosciences, University of São Paulo (São Paulo, Brazil), weighing 180-230 g were housed in individual cages under a regular light-dark cycle (lights on at 7:00 AM and off at 7:00 PM) in temperature-and humidity-controlled rooms. The animals received food and water ad libitum and were used for radioautographic studies. For dorsomedial brainstem cell culture, we used 1-d-old neonatal SHR and WKY rats (P 1 ) from the Butanta Institute, São Paulo, Brazil. All procedures and protocols were in accordance with our Institutional Guidelines for Animal Experimentation.
Quantitative Receptor Radioautography
The procedure for quantitative receptor radioautography has been described elsewhere ( 16 ) . Coronal sections (20 μ m thick) of the medulla oblongata were made in a Leica cryostat (CM3050) at bregma levels from − 14.30 to − 13.30 mm, consistent with the atlas proposed by Paxinos and Watson ( 24 ) , and subsequently thaw-mounted on gelatin-coated slides for radioautography. We studied the in vitro NTS-based modulatory effect of N 6 -cyclopentyladenosine (CPA) (Sigma, St. Louis, USA), an adenosine A 1 receptor agonist, on the characteristics of [ 3 H]RX821002 (specific activity 62 Ci/mmol, Amersham) binding, an α 2 -adrenoceptor antagonist. We used saturation experiments, which were performed using 10 different concentrations of [ 3 H]RX821002 (0.5-20 nmol/L) in the presence or absence of 3 different concentrations of CPA (1, 10, 30 nmol/L). A total of 10 μmol/L of phentolamine (Sigma), an α2-adrenoceptor antagonist, was used for nonspecific binding and 300 nmol/L of DPCPX (Sigma), an ade-nosine A 1 receptor antagonist, was used to block the modulatory effect promoted by CPA. The solvent used for DPCPX was ethanol. The effect of ethanol was also evaluated as an experimental control.
Forty adjacent sections from bregma levels − 14.30 to − 13.30 mm were obtained and separated in both the control (absence of CPA) and the treated groups (1, 10, and 30 nmol/ L of CPA). All groups were equally distributed among the rostral-caudal sections for saturation experiments in a single rat for a total of six rats ( n = 6). The same procedure was performed to establish nonspecific binding using phentolamine.
Slide-mounted brain sections were pre-incubated with TrisHCl buffer (170 mmol/L, pH 7.4) containing 0.2 U/mL of adenosine deaminase (ADA) (Sigma) at room temperature for 15 min to remove endogenous adenosine. The sections were then pre-incubated in a buffer of the same composition, with or without CPA (1, 10, 
Dorsomedial Brainstem Cell Culture and [
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The procedure for brainstem cell culture has been described 
Weak radioactive labeling was observed in the dorsal motor nucleus of the vagus nerve (X in B, C) and hypoglossal nucleus (XII in B, C). 4V, 4th ventricle.
elsewhere ( 27 ) The cell culture was washed (3 × 5 min) using Krebs Ringer bicarbonate buffer (KRGB), pH 7. 3 H]RX821002 binding. The solvent used for DPCPX was ethanol. The effect of ethanol was also evaluated as an experimental control (data not shown). Ethanol had no effect on [ 3 H]RX821002 binding. Following incubation, the cells were washed in the same KRGB cold buffer (3 × 3 min), resuspended in deionized cold distilled water (4°C), and immersed in scintillation cocktail (Ecolume; ICN Biomedicals, Aurora, USA). The radioactivity was measured (Packard TriCarb 2100TR; Downers Grove, USA). Protein concentration was determined using the method of Bradford (28) and the result was expressed in terms of fmol/mg of protein.
Statistical Analysis
Statistical analysis was performed using the repeated-measures ANOVA test, followed by Dunnett's test, to compare different treatments against the control group. For radioautographic studies, the values from the control group and the treated group were compared considering the binding parameters (Bmax and Kd) obtained using the GRAPHPAD program (Intuitive Software for Science, San Diego, USA). *p< 0.05, n= 6.
Results
Dense radioactive labeling of α2-adrenoceptors by [ 3 H]RX821002 was well defined in the NTS at intermediate levels ( Fig. 1A ) (−13.80 mm from bregma), rostral levels ( Fig. 1B ) (−13.30 mm from bregma) and caudal levels ( Fig. 1B and C) . The modulatory effect of CPA on α2-adrenoceptors was analyzed in these subnuclei. Weak radioactive labeling was observed in the dorsal motor nucleus of the vagus nerve (X in Fig. 1B and C) and in the hypoglossus nucleus (XII in Fig. 1B and C) .
Adenosine A1 Receptors Modulate 2 -Adrenoceptors in Normotensive Rats (WKY)
The dorsomedial/dorsolateral subnucleus within the NTS showed an increase in B max value of [ 3 H]RX821002 (21%) induced by 10 nmol/L of CPA compared with the control group without CPA (Fig. 2A, dorsomedial/ Fig. 2A , dorsomedial/dorsolateral, subpostremal). DPCPX also blocked the modulatory effect promoted by 10 nmol/L of CPA on α2-adrenoceptors ( Fig. 2A) 
nmol/L of CPA ( • ) compared with the control group ( ▲ ). The 30 nmol/L curves are not shown because this concentration had no effect on any subnuclei for any concentration of CPA. A total of 10 μ mol/L of phentolamine was used as a non-specific binding agent. Statistical analysis is shown in A. Inset: Scatchard plots (same data) showing K d and B max values. M: mol/L.
Fig. 3. Effect of CPA (1, 10, and 30 nmol/L) on the characteristics of [ 3 H]RX821002 binding in subnuclei dorsomedial/dorsolateral, subpostremal and medial/intermediate subnuclei of spontaneously hypertensive rats (SHR)
.
nmol/L of CPA (■) compared with the control group (▲). The 30 nmol/L curves were not shown because this concentration had no effect on any subnuclei regardless of CPA concentration. A total of 10 μmol/L of phentolamine was used as a non-specific binding agent. Statistical analysis is shown in A. Inset: Scatchard plots (same data) showing Kd and Bmax values. M: mol/L.
compared with the CPA-free control group (Fig. 3A, (Fig. 3A, subpostremal) . No changes were observed in B max value using 1 nmol/L of CPA at this subnucleus. Similarly, 10 and 30 nmol/L of CPA had no effect on either the B max (Fig. 3A , dorsomedial/dorsolateral, subpostremal). DPCPX also blocked the modulatory effect of 1 nmol/L of CPA on α2-adrenoceptors (Fig. 3A) . mol/L of CPA (53%) (Fig. 4A ). Dorsomedial brainstem cell culture of SHR rats also showed an increase in 
Modulatory Effect of
Discussion
Our study offers evidence for the existence of a complex interaction between adenosine A 1 receptors and α 2 -adrenoceptors within the NTS of Wistar-Kyoto normotensive (WKY) and spontaneously hypertensive rats (SHR). Sections from the medulla oblongata of WKY and SHR showed that CPA, an adenosine A 1 agonist, induces an increase in the B max and a decrease in the K d values of [ 3 H]RX821002 binding in the dorsomedial/dorsolateral and subpostremal subnuclei of the NTS, respectively. These CPA-induced changes are altered in hypertensive rats. Our results suggest that a very well-organized network of modulation might impact different subnuclei within the NTS in order to elicit appropriate autonomic responses. This finding was confirmed by experiments with neuronal cell cultures from normotensive and hypertensive rats.
Adenosine exhibits a differential action within the NTS. Microinjection of adenosine into the caudal NTS of rats elicits a potent dose-related decrease in blood pressure and heart rate ( 5 , 20 ) . However, at more rostral sites, adenosine administration exerts a pressor effect ( 20 ) . In agreement with this fact, previous research from our laboratory and others have reported the existence of separated populations of adenosine receptors within the NTS showing increased concentrations of adenosine A 1 receptors in the rostral region compared with the caudal zone ( 3 , 11 ) . The results suggested separate populations of adenosine receptors and also indicated a heterogeneous distribution of adenosine A 1 receptors within the NTS.
Researchers reported increased receptor concentrations in the dorsomedial/dorsolateral and subpostremal subnuclei ( 11 ) . We argue that the changes in binding parameters of α 2 -adrenoceptor observed in our study in these specific subnuclei provide strong evidence for an interaction between adenosine A 1 receptors and α 2 -adrenoceptors.
Barraco and Phillis ( 4 ) have reported that stimulating adenosine A 1 receptors in the subpostremal NTS can evoke a pressor response. This action also increases the heart rate and impacts other regional sympathetic control activity ( 9 , 10 ). Therefore, although the pressor responses to stimulation of the NTS adenosine A 1 receptor were clearly dominant, biphasic or depressor responses were also observed in approximately 30% of cases ( 6 ) It is interesting to note that stimulation of the NTS A 2a receptor evokes preferential hindlimb vasodilatation in a uniform manner ( 30 ) . In contrast, NTS adenosine A 1 receptor stimulation elicits β -adrenergic vasodilatation in the hindlimb vascular bed and simultaneously triggers neural and humoral vasoconstriction, leading to marked variability in hemodynamic response ( 6 ) . This means that stimulation of adenosine A 1 receptors within the NTS can elicit different autonomic responses in different regions of the body in order to maintain homeostasis. Thus, we would suggest that adenosine A 1 receptors may regulate the pressure response in a particular way at different subnuclei within the orchestrated processing of the NTS neurons. This might explain why CPA induced an increase in the B max in one subnucleus and a decrease in the The major finding from our study was that CPA in the nanomolar range of 1 nmol/L for SHR and 10 nmol/L for WKY significantly changed the number and the affinity of α 2 -adrenoceptors at the dorsomedial/dorsolateral and the subpostremal subnuclei, respectively. However, the CPA-induced effect disappeared with higher CPA concentrations. We also observed a pattern of dose-response using neuronal cultures from normotensive and hypertensive rats (Fig. 4) . This type of U-shape or inversely U-shape dose-response curve has been observed for other receptor-receptor interactions such as α 2 -adrenoceptor/neuropeptide Y ( 31 ), angiotensin II/ α 2 -adrenoceptors ( 15 , 16 ) , and bradykinin/ α 2 -adrenoceptor ( 32 ). Our results could be due to a desensitization phenomenon, to a depletion of a factor necessary for the interaction to take place, or even because of a gradual dosedependent conformational change. The interaction between the adenosine receptor and other receptors has also been reported; examples include adenosine A 2A /dopamine D 2 and adenosine A 1 /dopamine D 1 ( 17 , 33 ) .
Our finding that SHR and WKY rats showed similar changes of comparable intensity was surprising because other researchers have reported increased concentrations of adenosine A 1 receptors within the NTS of SHR compared with WKY rats ( 11 , 22 ) . High numbers of adenosine A 1 receptors within the NTS of SHR rats would, in theory, allow for higher activation rates of this receptor and a concomitant increase in the number of α 2 -adrenoceptors, thereby increasing the depressor response mediated by noradrenaline. Consequently, adenosine A 1 receptor stimulation would promote an attenuated pressor response within the NTS of SHR, as demonstrated by Tseng et al . ( 34 ) . Accordingly, although our results did not show a greater increase in the number of α 2 -adrenoceptors in SHR compared with WKY mediated by the adenosine A 1 analog, we did find that the α 2 -adrenoceptor system is responsive to a lower dose of adenosine A 1 analogs in SHR than in WKY rats. This means that adenosine A 1 analogs are more potent in modulating α 2-adrenoceptor system within the NTS of hypertensive than normotensive rats. We conclude that the SHR α2-adrenoceptor system may promote an increased hypotensive output in the presence of adenosine A1 agonist compared with WKY rats in certain specific subnuclei. It is important to note that this is a small increase in hypotensive response in the context of the total hypertensive output, because blood pressure in SHR is higher than normal. This hypothesis agrees with a recent functional study, which suggested that the SHR rats exhibit attenuated pressor, tachycardic and neuronal responses mediated by adenosine compared with WKY rats (34) .
One explanation for the modulatory effect of adenosine on α2-adrenoceptors could be linked to a compensatory mechanism, given that α2-adrenoceptor concentration is decreased in SHR animals. We speculate that this modulatory effect may prevent a higher increase in blood pressure in these animals.
The same pattern of the result obtained from analyzing tissue sections was also observed in cell culture from the brainstems of SHR and WKY animals. Brainstem cells from SHR animals were also more responsive than those of WKY (Fig.  4) . This result not only confirms our tissue sectioning data but also highlights a difference in the neurotransmission pathways of SHR and WKY very early in life. To our knowledge, this result is the first to report such modulation in cell cultures taken from newborn rats. This is particularly interesting because hemodynamic parameters are not altered at this age. Differences in blood pressure between the strains appear around 2 months of age (35) . Strain-dependent changes before 2 months of age might be particularly relevant to the development of high blood pressure. Indeed, several studies show adenosine A1 receptor alterations at the early stages of SHR development (22, 26, 36) . In addition, our group has found that the subpostremal subnucleus seems to be particularly important for the development of hypertension in the SHR, because changes in adenosine A1 receptor binding between strains (SHR-WKY) were observed in this subnucleus in 15-d-old rats (26) . Our data suggest that an altered neurotransmission, in this case an interaction between A1/α2-adrenoceptor, might be causally related to the development of hypertension.
It is important to recognize that α2-adrenoceptor concentrations are decreased during early stages of development (21) . The sensitization of α2-adrenoceptors by the A1 agonist in SHR cell cultures from newborns compared with WKY might suggest that the interaction between A1/α2 occurs early in life. This mechanism might be important in regulating blood pressure in SHR animals during development.
These results highlight for the first time the nature of adenosine-related modulatory effects within specific subnuclei of the NTS neuronal circuitry. These effects may, in turn, play a role in promoting a complex autonomic response. In conclusion, our work offers a valuable contribution to understanding the action of a potent endogenous modulator such as adenosine in changing the nature of α2-adrenoceptors. Our results emphasize the importance of a careful analysis of adenosine activity sites within the NTS. Phenomena such as the interaction between adenosine A1 receptors and α2-adrenoceptors suggest promising new approaches for drug development in the context of blood pressure disorders.
